Partial androgen insensitivity syndrome due to somatic mosaicism of the androgen receptor
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WALTER DE GRUYTER GMBH
Citação
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, v.31, n.2, p.223-228, 2018
Resumo
Background: Androgen insensitivity syndrome (AIS) is the most frequent etiology of 46, XY disorders of sex development (DSDs), and it is an X-linked disorder caused by mutations in the androgen receptor (AR) gene. AIS patients present a broad phenotypic spectrum and individuals with a partial phenotype present with different degrees of undervirilized external genitalia. There are more than 500 different AR gene allelic variants reported to be linked to AIS, but the presence of somatic mosaicisms has been rarely identified. In the presence of a wild-type AR gene, a significant degree of spontaneous virilization at puberty can be observed, and it could influence the gender assignment, genetic counseling and the clinical and psychological management of these patients and the psychosexual outcomes of these patients are not known. Case presentation: In this study, we report two patients with AR allelic variants in heterozygous (c.382G>T and c.1769-1G>C) causing a partial AIS (PAIS) phenotype. The first patient was raised as female and she had undergone a gonadectomy at puberty. In both patients there was congruency between gender of rearing and gender identity and gender role. Conclusions: Somatic mosaicism is rare in AIS and nonsense AR variant allelic can cause partial AIS phenotype in this situation. Despite the risk of virilization and prenatal androgen exposure, the gender identity and gender role was concordant with sex of rearing in both cases. A better testosterone response can be expected in male individuals and this should be considered in the clinical management.
Palavras-chave
androgen insensitivity syndrome, androgen receptor gene, gender assignment, heterozygous X-linked mutations, somatic mosaicism, 46, XY disorders of sex development (DSD)
Referências
- Arnhold IJP, 2011, ADV EXP MED BIOL, V707, P59, DOI 10.1007/978-1-4419-8002-1_14
- BATCH JA, 1993, ARCH DIS CHILD, V68, P453, DOI 10.1136/adc.68.4.453
- Batista RL, 2017, SEX DEV, V11, P78, DOI 10.1159/000468957
- Evans BAJ, 1997, ARCH DIS CHILD, V76, P529, DOI 10.1136/adc.76.6.529
- Fujii C, 2016, PEDIATR INT, V58, P8, DOI 10.1111/ped.12790
- Gottlieb B, 2001, TRENDS GENET, V17, P79, DOI 10.1016/S0168-9525(00)02178-8
- Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046
- HIORT O, 1993, J CLIN ENDOCR METAB, V77, P262, DOI 10.1210/jc.77.1.262
- Hiort O, 2013, ENDOCR DEV, V24, P33, DOI 10.1159/000342499
- Holterhus PM, 1997, J CLIN ENDOCR METAB, V82, P3584, DOI 10.1210/jc.82.11.3584
- Holterhus PM, 1999, PEDIATR RES, V46, P684, DOI 10.1203/00006450-199912000-00009
- Hughes IA, 2012, SEMIN REPROD MED, V30, P432, DOI 10.1055/s-0032-1324728
- Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971
- Kohler B, 2005, J CLIN ENDOCR METAB, V90, P106, DOI 10.1210/jc.2004-0462
- Lucas-Herald A, 2016, J CLIN ENDOCR METAB, V101, P3959, DOI 10.1210/jc.2016-1372
- Melo KFS, 2003, J CLIN ENDOCR METAB, V88, P3241, DOI 10.1210/jc.2002-021658
- Mongan NP, 2015, BEST PRACT RES CL EN, V29, P569, DOI 10.1016/j.beem.2015.04.005
- Oakes MB, 2008, J PEDIATR ADOL GYNEC, V21, P305, DOI 10.1016/j.jpag.2007.09.006
- Palmer L, 2000, Child Maltreat, V5, P169, DOI 10.1177/1077559500005002008
- RIERDAN J, 1981, J PERS ASSESS, V45, P256, DOI 10.1207/s15327752jpa4503_5
- Veiga-Junior NN, 2012, INT J ENDOCRINOL, V2012